Medtronic Investors Get Shady-Study Suit Redo In 8th Circ.
The Eighth Circuit has revived a class action alleging medical device maker Medtronic Inc. knowingly manipulated studies for its Infuse bone graft products to drive up share prices, tossing a district...To view the full article, register now.
Already a subscriber? Click here to view full article